Date Log
Diabetes mellitus associated mortality: Therapy and awareness
Corresponding Author(s) : Sara Nikhat
International Journal of Allied Medical Sciences and Clinical Research,
Vol. 3 No. 1 (2015): 2015 Volume 3- Issue -1
Abstract
United States studies have estimated nearly 1 million Americans, or 9.3% of the population had diabetes mellitus in the year 2012 and contributed to 234,051 deaths per annum which lead to Diabetes remains the 7th leading cause of death in the United States. This study revealed risk factors associated with various co-morbidities due to increased blood glucose levels such as hypertension, stroke, heart attacks, kidney diseases, lower limb amputations. The report from “American Diabetes Association” survey to examine awareness and pharmacological treatment of uncontrolled diabetes mellitus among age groups with special emphasis on three groups which includes ,Persons unaware of diabetes, Persons who are aware but not treated with medication, Persons who are aware and pharmacologically treated with medication but still have uncontrolled. The objective of present work is to create the awareness for diabetes mellitus and it’s therapy. The “National Diabetes Statistics” 2014 report of United States reveals in year 2012 about 86 million Americans age 20 and older had prediabetes. Out of the 29.1 million, 8.1 million were undiagnosed. We assessed in our findings that maximum percentage of patients who are diabetic but not adhering to medicine due to it's high cost. we should use different strategies and various awareness programs viz Marathons, flash mobs to significantly reduce the Diabetes associated mortality cases.This article represent the application of selected statistical tools such as "SPSS" software for data analysis for assessing the increasing mortality due to Diabetes.
Keywords
Download Citation
Endnote/Zotero/Mendeley (RIS)BibTeX
-
[1] National Diabetes Data Group. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 1979; 28: 1039–57.
[2] The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997; 20: 1183–97.
[3] Alberti KGMM, Zimmet PZ for the WHO Consultation. Classification of diabetes mellitus and its complications. Part 1: classification of diabetes mellitus. Provisional report of a WHO Co.
[4] https://www.staff.ncl.ac.uk/philip.home/who_dmc.htm#Introduction.
[5] Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care.
[6] A Desktop Guide for the Management of Non-Insulin Dependent Diabetes Mellitus. A contribution to the implementation of the St. Vincent Declaration, WHO/EURO and IDF, 1993.
[7] Consensus Guidelines for the Management of Insulin-Dependent (type 1) Diabetes, European IDDM Policy Group, 1993
[8] Ozougwu, J. C. The pathogenesis and pathophysiology of type 1 and type 2 diabetes mellitus. DOI 10.5897/JPAP2013.0001 Vol. 4(4), pp. 46-57.
[9] Davis, S.N., Butler, P.C., Brown, M., et al. The effects of human proinsulin on glucose turnover and intermediary metabolism. Metabolism, 1991, 40:953–961. [PMID: 1895960]
[10] American Diabetes Association. Consensus statement on pharmacologic treatment. Diabetes Care, 1999,21:s1-114.
[11] Temple, R.C., Carrington, C.A., Luzio, S.D., et al. Insulin deficiency in non-insulin-dependent diabetes. Lancet, 1989, 1:2
References
[2] The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997; 20: 1183–97.
[3] Alberti KGMM, Zimmet PZ for the WHO Consultation. Classification of diabetes mellitus and its complications. Part 1: classification of diabetes mellitus. Provisional report of a WHO Co.
[4] https://www.staff.ncl.ac.uk/philip.home/who_dmc.htm#Introduction.
[5] Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care.
[6] A Desktop Guide for the Management of Non-Insulin Dependent Diabetes Mellitus. A contribution to the implementation of the St. Vincent Declaration, WHO/EURO and IDF, 1993.
[7] Consensus Guidelines for the Management of Insulin-Dependent (type 1) Diabetes, European IDDM Policy Group, 1993
[8] Ozougwu, J. C. The pathogenesis and pathophysiology of type 1 and type 2 diabetes mellitus. DOI 10.5897/JPAP2013.0001 Vol. 4(4), pp. 46-57.
[9] Davis, S.N., Butler, P.C., Brown, M., et al. The effects of human proinsulin on glucose turnover and intermediary metabolism. Metabolism, 1991, 40:953–961. [PMID: 1895960]
[10] American Diabetes Association. Consensus statement on pharmacologic treatment. Diabetes Care, 1999,21:s1-114.
[11] Temple, R.C., Carrington, C.A., Luzio, S.D., et al. Insulin deficiency in non-insulin-dependent diabetes. Lancet, 1989, 1:2